US limits use of J&J's Covid vaccine on blood clot risks | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Wednesday
December 06, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
WEDNESDAY, DECEMBER 06, 2023
US limits use of J&J's Covid vaccine on blood clot risks

USA

Reuters
07 May, 2022, 05:50 pm
Last modified: 07 May, 2022, 05:54 pm

Related News

  • Trump: I won't be a dictator if I become U.S. president again
  • Despite Gaza death toll soaring, U.S. unlikely to rethink weapons supplies to Israel
  • US announces visa bans after warning Israel over West Bank violence
  • The Pentagon wants to root out shoddy drugs. The FDA is in its way.
  • US examined Hindenburg allegations before giving loan to Adani

US limits use of J&J's Covid vaccine on blood clot risks

Reuters
07 May, 2022, 05:50 pm
Last modified: 07 May, 2022, 05:54 pm
The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019/Reuters
The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019/Reuters

The US health regulator said on Thursday it was limiting the use of Johnson & Johnson's Covid-19 vaccine for adults due to the risk of a rare blood clotting syndrome, the latest setback to the shot that has been eclipsed by rivals.

The J&J shot, which received US clearance in February 2021 for adults, can be administered in cases where authorized or approved Covid-19 vaccines are not accessible or if an individual is less keen on using the other two shots, the Food and Drug Administration said.

J&J is one of the three vaccines in use in the United States. The other two are from Moderna and Pfizer .

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The vaccine maker said it has updated the US Covid-19 vaccine fact sheet to warn about the risk of thrombosis with thrombocytopenia syndrome (TTS), a rare but potentially life-threatening condition.

Use of the J&J shot has been weak in high-income countries, hurt by reports of rare, potentially deadly blood clots, production issues, including an accidental mix-up of ingredients by a contract manufacturer, and concerns about efficacy.

The drugmaker last month rescinded its forecast for Covid-19 vaccine sales, citing a glut of supply.

Cases of TTS, which involves blood clots accompanied by a low level of platelets, have previously been reported in recipients of the J&J vaccine.

The FDA in January amended the fact sheet for the J&J vaccine to include the risk of immune thrombocytopenia, months after the European Union's drugs regulator took similar action.

The FDA on Thursday said the risk of TTS warranted limiting the use of the single-dose shot after it conducted investigation of reported cases.

The US Centers for Disease Control and Prevention in December had recommended that Americans choose to receive mRNA shots from Pfizer and Moderna over J&J's vaccine due to the rare cases of blood clotting.

Around 18.7 million Americans have received a J&J Covid-19 shot compared with 217.5 million people who received the Moderna vaccine and 340.6 million people who received Pfizer's shot, according to CDC.

Coronavirus chronicle / Top News / World+Biz

Jhonson and jhonson / USA / J&J Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Prime Minister Sheikh Hasina. File Photo: UNB
    Saudi Arabia an important dev partner of Bangladesh: PM Hasina
  • Prime Minister Sheikh Hasina. Sketch: TBS
    PM Hasina 46th on Forbes list of most powerful women
  • File photo: Collected
    BNP now Jamaat's 'B-team': Quader

MOST VIEWED

  • Caption: Illustration: TBS
    Source tax on land registration cut again
  • This file photo from December 2019 shows a rider driving his motorcycle through cold wind and fog. A scene not yet visible this year. Photo: Mumit M
    Woe for seasonal crops, vegetables as winter comes late 
  • File Photo: Reuters
    $1.08 billion could be added to Bangladesh's dwindling forex reserves
  • Photo: Courtesy
    Woman entrepreneur Sangeeta Khan dies at age 62
  • 59 DSE stocks face downgrade to junk category
    59 DSE stocks face downgrade to junk category
  • Dollar pressure rises as short-term foreign debt drops $300m in October
    Dollar pressure rises as short-term foreign debt drops $300m in October

Related News

  • Trump: I won't be a dictator if I become U.S. president again
  • Despite Gaza death toll soaring, U.S. unlikely to rethink weapons supplies to Israel
  • US announces visa bans after warning Israel over West Bank violence
  • The Pentagon wants to root out shoddy drugs. The FDA is in its way.
  • US examined Hindenburg allegations before giving loan to Adani

Features

Dhaka’s FDC,  Japan Garden City and Shia Masjid were all part of Gudaraghat once. PHOTOS:  Syed Zakir Hossain

What the remaining Gudaraghats remind us of Dhaka's long-lost water bodies

7h | Panorama
A trove of research underscores the perilous consequences of relying on plastic utensils, a narrative mirrored by the western world's pivot towards sustainable alternatives - ceramic, brass, or clay dinnerware. PHOTO: TBS

While we lose our sustainable traditions, the West pivots in the opposite direction

6h | Panorama
Ghulam Ali

Ghulam Ali: Voice that makes ghazals bloom

1d | Features
Exploring door designs: Redefining spaces and experiences

Exploring door designs: Redefining spaces and experiences

1d | Habitat

More Videos from TBS

Most Ukrainians are losing interest in going to war

Most Ukrainians are losing interest in going to war

1h | TBS World
Putin to visit UAE and Saudi Arabia

Putin to visit UAE and Saudi Arabia

3h | TBS World
Will the United States - Israel attack Yemen?

Will the United States - Israel attack Yemen?

17h | TBS World
Ukraine faces challenges in securing financing and sustaining energy infrastructure

Ukraine faces challenges in securing financing and sustaining energy infrastructure

5h | TBS World
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]